HH
PRTK

Hilltop Holdings’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Hilltop Holdings’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,950
Closed -$107K – 407
2018
Q4 		$107K Sell
20,950
-11,850
-36% -$90K 0.03% 329
2018
Q3 		$318K Sell
32,800
-1,500
-4% -$15.1K 0.07% 314
2018
Q2 		$350K Sell
34,300
-3,100
-8% -$35.1K 0.07% 279
2018
Q1 		$486K Buy
+37,400
New +$557K 0.09% 233

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hilltop Holdings's PRTK Position: Q1 2019 in Review

Hilltop Holdings sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q1 2019, closing a stake of 20,950 shares — an estimated $107K sold.

Hilltop Holdings first reported a position in PRTK in Q1 2018 and held it in 4 quarters. The position peaked at $486K in Q1 2018. 94 funds tracked by Wall St. Rank hold PRTK as of Q1 2019.

  • Hilltop Holdings reported no remaining Paratek Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Hilltop Holdings sold 20,950 Paratek Pharmaceuticals, Inc. shares in Q1 2019, an estimated $107K.
  • Hilltop Holdings first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2018 and held it in 4 quarters.
  • Hilltop Holdings's Paratek Pharmaceuticals, Inc. position peaked at $486K in Q1 2018.
  • 94 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2019.

Based on Hilltop Holdings's 13F filing for Q1 2019, filed 15 May 2019.